The Use of Rectal Balloons in Radical Pelvic Radiotherapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to test the hypothesis that insertion of an endorectal balloon into a patient receiving radical prostate radiotherapy by treatment radiographers is feasible without the patient experiencing undue discomfort. In addition this study will test the hypotheses that insertion of the rectal balloon prior to radiotherapy delivery stabilises rectal volume during radiotherapy treatment and minimises organ motion within the pelvis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer

NCT04323722

Rectal Cancer

COMPLETED NA

Care of Cancer Patients With Bowel Injury Caused by Radiation Therapy to the Pelvis

NCT00737230

Cancer

COMPLETED NA

Palliative Short-Course Radiotherapy in Rectal Cancer

NCT02639403

Rectal Neoplasms

COMPLETED PHASE2

The Impact of Patient Positioning and Use of Belly Board on Small Bowel and Urinary Bladder Volume Irradiated in Patients Receiving Radiotherapy for Rectal Cancer: A Prospective Phase II Study

NCT01142713

Rectal Cancer

UNKNOWN PHASE2

Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial

NCT05877352

Locally Advanced Rectal Cancer Locally Recurrent Rectal Cancer

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Endorectal Balloon insertion

A cone Beam scan will be performed prior to balloon insertion and then again with balloon in situ. The scans will be compared to see if the organs are stabilised. Questionnaires will be completed by the radiographer and the patient.

Group Type EXPERIMENTAL

Endorectal Balloon insertion

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endorectal Balloon insertion

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age greater than or equal to 18 years
* ECOG performance status 0-2 (Patients with PS-2 as a result of comorbidity will be excluded).
* Patients with histologically confirmed diagnosis of prostate adenocarcinoma
* Patients who are going to undergo treatment with radical radiotherapy for prostate cancer.
* Patients must be able to receive and understand verbal and written information regarding the study and give written, informed consent
* Patients must be able to comply with trial requirements.

Exclusion Criteria

* Patients must not have a history of previous bowel surgery involving the rectum or anus.
* Evidence of significant clinical disorder or laboratory finding which, in the opinion of the investigator makes it undesirable for the patient to participate in the trial, as well as any other serious uncontrolled medical condition.
* Any patient with a medical or psychiatric condition that impairs their ability to give informed consent
* Pre-existing anorectal disease, e.g. Haemorrhoids, active bleeding, anal irritation, inflammatory bowel disease.
* Patients who are unable to give consent.
* Patients in clinical trials of new investigational medicinal products or treatment regimens unless there is written, prior agreement that the patient can also consent to this study, and that clinical data can also be used for this study.
* Prior pelvic radiotherapy

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No